DOSSIER · 13F Holders · Q1 2025Healthcare · Drug Manufacturers
ITCIEUR
INTRA-CELLULAR THERAPIES INC
3 institutions still hold INTRA-CELLULAR THERAPIES INC as of Q1 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 46116X101·Drug Manufacturers·3 13F holders·last filed Mar 31, 2025
AI Holders Summary · Q1 2025
3 institutions reported ITCIEUR in Q1 2025. Orion Portfolio Solutions, LLC leads at 97.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.